Apyx medical corporation announces peer-reviewed publication featuring results from the u.s. ide clinical study evaluating the renuvion® dermal handpiece using apyx's helium plasma technology for dermal resurfacing procedures

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), a maker of medical devices, and supplier and the developer of helium plasma technology, marketed and sold as renuvion® in the cosmetic surgery market and j-plasma® in the hospital surgical market, today announced the publication of a peer-reviewed article in the journal, lasers in surgery and medicine, the official journal of the american society for laser medicine & surgery, featuring the results of
APYX Ratings Summary
APYX Quant Ranking